Gainers
- Quantum-Si QSI stock rose 144.9% to $1.55 during Wednesday's pre-market session. The company's market cap stands at $221.2 million.
- Forte Biosciences FBRX shares moved upwards by 76.53% to $10.46. The company's market cap stands at $15.2 million. The company's, Q3 earnings came out 4 days ago.
- Silexion Therapeutics SLXN stock rose 72.36% to $0.39. The company's market cap stands at $5.6 million. As per the news, the Q3 earnings report came out 4 days ago.
- Tonix Pharmaceuticals TNXP shares moved upwards by 57.59% to $0.26. The market value of their outstanding shares is at $47.9 million.
- Exicure XCUR shares rose 21.13% to $7.05. The company's market cap stands at $15.3 million. As per the press release, Q3 earnings came out 4 days ago.
- Tevogen Bio Holdings TVGN shares moved upwards by 19.85% to $1.63. The company's market cap stands at $278.1 million.
Losers
- Lineage Cell Therapeutics LCTX shares declined by 19.7% to $0.72 during Wednesday's pre-market session. The company's market cap stands at $136.9 million. As per the press release, Q3 earnings came out 4 days ago.
- Apollomics APLM shares declined by 17.23% to $0.14. The company's market cap stands at $14.9 million.
- BrightSpring Health BTSGU stock declined by 16.86% to $56.38.
- Oncology Institute TOI stock fell 15.56% to $0.15. The market value of their outstanding shares is at $11.4 million.
- HCW Biologics HCWB shares declined by 15.35% to $0.93. The market value of their outstanding shares is at $35.2 million. As per the news, the Q3 earnings report came out 4 days ago.
- Eyenovia EYEN shares decreased by 13.93% to $0.1. The market value of their outstanding shares is at $8.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in